Predictors of hemodynamic instability during surgery for pheochromocytoma
- PMID: 24939623
- PMCID: PMC4192065
- DOI: 10.1245/s10434-014-3847-7
Predictors of hemodynamic instability during surgery for pheochromocytoma
Abstract
Background: Resection of pheochromocytoma is often associated with hemodynamic instability (HDI). We examined patient and tumor factors that may influence HDI. The effect of pretreatment with nonselective α blockade phenoxybenzamine (PXB) versus selective α blockade on HDI and outcomes was also evaluated.
Methods: The records of 91 patients who underwent adrenalectomy between 2002 and 2013 were retrospectively reviewed. HDI was determined by number of intraoperative episodes of systolic blood pressure (SBP) > 200 mmHg, those greater than or less than 30 % of baseline, heart rate > 110 bpm, and the need for postoperative vasopressors. Fishers exact, t test and regressions were performed.
Results: Among 91 patients, 78 % received PXB, 18 % selective α blockade and 4 % no adrenergic blockade. Patient demographics, tumor factors and surgical approach were similar among the blockade groups. On multivariate analysis, increasing tumor size was associated with a significant rise in the number of episodes of SBP > 30 % [rate ratio (RR) 1.40] and an increased postoperative vasopressor requirement [odds ratio (OR) 1.23]. Open adrenalectomy and use of selective blockade were associated with an increased number of episodes of SBP > 200 mmHg (RR 27.8 and RR 20.9, respectively). Open adrenalectomy was also associated with increased readmissions (OR 12.3), complications (OR 5.6), use of postoperative vasopressors (OR 4.4) and hospital stay (4.6 days longer). There were no differences in other HDI measurements or postoperative outcomes among the blockade groups.
Conclusions: Tumor size, open adrenalectomy, and type of α blockade were associated with intraoperative HDI during pheochromocytoma resection. Selective blockade was associated with significantly more episodes of intraoperative hypertension but no perioperative adverse outcomes.
Similar articles
-
Selective Versus Non-selective α-Blockade Prior to Laparoscopic Adrenalectomy for Pheochromocytoma.Ann Surg Oncol. 2017 Jan;24(1):244-250. doi: 10.1245/s10434-016-5514-7. Epub 2016 Aug 25. Ann Surg Oncol. 2017. PMID: 27561909 Free PMC article.
-
Adrenalectomy for Pheochromocytoma: Complications and Predictive Factors of Intraoperative Hemodynamic Instability.Am Surg. 2023 Nov;89(11):4772-4779. doi: 10.1177/00031348221135774. Epub 2022 Oct 27. Am Surg. 2023. PMID: 36302517
-
Side-specific factors for intraoperative hemodynamic instability in laparoscopic adrenalectomy for pheochromocytoma: a comparative study.Surg Endosc. 2024 Aug;38(8):4571-4582. doi: 10.1007/s00464-024-10974-w. Epub 2024 Jul 1. Surg Endosc. 2024. PMID: 38951238 Free PMC article.
-
Selective vs non-selective alpha-blockade prior to adrenalectomy for pheochromocytoma: systematic review and meta-analysis.Eur J Endocrinol. 2021 May 4;184(6):751-760. doi: 10.1530/EJE-20-1301. Eur J Endocrinol. 2021. PMID: 33769959
-
Preoperative α-blockade versus no blockade for pheochromocytoma-paraganglioma patients undergoing surgery: a systematic review and updated meta-analysis.Int J Surg. 2023 May 1;109(5):1470-1480. doi: 10.1097/JS9.0000000000000390. Int J Surg. 2023. PMID: 37037514 Free PMC article.
Cited by
-
The Duration of Preoperative Administration of Single α-Receptor Blocker Phenoxybenzamine before Adrenalectomy for Pheochromocytoma: 18 Years of Clinical Experience from Nationwide High-Volume Center.Biomed Res Int. 2019 Nov 16;2019:2613137. doi: 10.1155/2019/2613137. eCollection 2019. Biomed Res Int. 2019. PMID: 31828097 Free PMC article.
-
Management of Patients with Treatment of Pheochromocytoma: A Critical Appraisal.Cancers (Basel). 2022 Aug 9;14(16):3845. doi: 10.3390/cancers14163845. Cancers (Basel). 2022. PMID: 36010839 Free PMC article. Review.
-
Intraoperative difficulty in cardiorespiratory management during anesthesia for retroperitoneal paraganglioma resection.SAGE Open Med Case Rep. 2023 Jul 8;11:2050313X231183881. doi: 10.1177/2050313X231183881. eCollection 2023. SAGE Open Med Case Rep. 2023. PMID: 37434894 Free PMC article.
-
Giant left pheochromocytoma with vascular anomalies and pelvic horseshoe kidney: a case report.BMC Urol. 2023 Dec 8;23(1):204. doi: 10.1186/s12894-023-01370-y. BMC Urol. 2023. PMID: 38066479 Free PMC article.
-
A Nomogram for Predicting Intraoperative Hemodynamic Instability in Patients With Pheochromocytoma.Front Endocrinol (Lausanne). 2022 Jan 6;12:787786. doi: 10.3389/fendo.2021.787786. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35069440 Free PMC article.
References
-
- DeLellis RA. Pathology and genetics of tumours of endocrine organs. Lyon: IARC Press; 2004.
-
- Bruynzeel H, Feelders RA, Groenland TH, van den Meiracker AH, van Eijck CH, Lange JF, et al. Risk Factors for Hemodynamic Instability during Surgery for Pheochromocytoma. The Journal of clinical endocrinology and metabolism. 2010;95(2):678–85. - PubMed
-
- Conzo G, Musella M, Corcione F, Depalma M, Stanzione F, Della-Pietra C, et al. Role of preoperative adrenergic blockade with doxazosin on hemodynamic control during the surgical treatment of pheochromocytoma: a retrospective study of 48 cases. The American surgeon. 2013;79(11):1196–202. - PubMed
-
- Kim HH, Kim GH, Sung GT. Laparoscopic adrenalectomy for pheochromocytoma: comparison with conventional open adrenalectomy. Journal of endourology / Endourological Society. 2004;18(3):251–5. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical